Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Embryonics is an Israeli health-tech company that leverages advanced deep learning and geometric deep learning to improve the success rates of fertility treatments. The company's core platform, UBAR, is an AI-driven clinical decision support tool designed to assist embryologists in selecting the most viable embryos for transfer during IVF procedures. By analyzing time-lapse videos and static images of embryos, the technology provides objective, data-driven scores that outperform traditional manual grading methods. Embryonics aims to democratize high-quality fertility care by reducing the number of failed cycles and lowering the overall cost of treatment for patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Embryonix.